Investor webinar: Activities and Plans moving forward
September 27, 2022
On September 27, 2022, at 10:00 AM, SDS Optics S.A. held an investor webinar titled “Activities and Plans”. During the live broadcast, the Company's Management Team summarized ongoing activities and presented development plans. Participants of the webinar learned more about the progress made in achieving the milestones set by the Company. The course of the inPROBE® clinical trials, which began in August, was presented. The Management Board discussed the development of the inPROBE® technology and the next phases of work on the diagnostic microsensor for HER2-positive breast cancers. The management team also provided an update on the construction of the Company’s own pilot production line for photonic biosensors. A key point of the webinar was the discussion of plans to scale the inPROBE® technology platform into infectious disease diagnostics (FiBioMed), as well as its application in drug delivery monitoring (pharmaceutical probe). A recording of the broadcast is available on the Company’s YouTube channel.
We Care About Your Privacy
SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.